Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Immunovant (IMVT) vs. Competitors

964 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
IMVTImmunovant$35.05$7.67B-13.8049.53%Moderate BuyUnlock the IMVT analyst price target with TipRanks PremiumIMVTUnlock the IMVT top-analyst price target with TipRanks Premium
TGTXTG Therapeutics$64.56$9.94B87.22108.19%Moderate BuyUnlock the TGTX analyst price target with TipRanks PremiumIMVT vs TGTXUnlock the TGTX top-analyst price target with TipRanks Premium
VRDNViridian Therapeutics$30.48$3.55B-7.895.32%Strong BuyUnlock the VRDN analyst price target with TipRanks PremiumIMVT vs VRDNUnlock the VRDN top-analyst price target with TipRanks Premium
AUPHAurinia Pharmaceuticals$16.21$2.17B6.874.31%Moderate BuyUnlock the AUPH analyst price target with TipRanks PremiumIMVT vs AUPHUnlock the AUPH top-analyst price target with TipRanks Premium
PTGXProtagonist Therapeutics$134.38$8.80B26.0958.37%Strong BuyUnlock the PTGX analyst price target with TipRanks PremiumIMVT vs PTGXUnlock the PTGX top-analyst price target with TipRanks Premium
KYMRKymera Therapeutics$127.17$11.51B-35.23100.17%Strong BuyUnlock the KYMR analyst price target with TipRanks PremiumIMVT vs KYMRUnlock the KYMR top-analyst price target with TipRanks Premium

Performance Comparison

-100%-50%0%50%100%150%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
IMVTImmunovant35.0512.2353.59%
TGTXTG Therapeutics64.5633.60108.53%
VRDNViridian Therapeutics30.481.996.98%
AUPHAurinia Pharmaceuticals16.210.996.50%
PTGXProtagonist Therapeutics134.3851.1461.44%
KYMRKymera Therapeutics127.1763.5499.86%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts